D103-2362 Screening compound: N~2~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-N~2~-(4-fluorobenzyl)-4-oxo-4H-chromene-2-carboxamide

D103-2362 Screening compound: N~2~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-N~2~-(4-fluorobenzyl)-4-oxo-4H-chromene-2-carboxamide
D103-2362 Screening compound: N~2~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-N~2~-(4-fluorobenzyl)-4-oxo-4H-chromene-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D103-2362
N~2~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-N~2~-(4-fluorobenzyl)-4-oxo-4H-chromene-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D103-2362

Molecular Formula

C21H18FNO5S (C21 H18 FNO5 S)

Compound Name

N~2~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-N~2~-(4-fluorobenzyl)-4-oxo-4H-chromene-2-carboxamide

IUPAC name

N-(11-dioxo-1lambda6-thiolan-3-yl)-N-[(4-fluorophenyl)methyl]-4-oxo-4H-chromene-2-carboxamide

SMILES

O=C(C(Oc1c2cccc1)=CC2=O)N(Cc(cc1)ccc1F)C(CC1)CS1(=O)=O

InChI

InChI=1S/C21H18FNO5S/c22-15-7-5-14(6-8-15)12-23(16-9-10-29(26,27)13-16)21(25)20-11-18(24)17-3-1-2-4-19(17)28-20/h1-8,11,16H,9-10,12-13H2/t16-/m1/s1

InChI Key

LOHULVVZXSKASG-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD06648994

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

415.44

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.030

Distribution Coefficient, logD

2.030

Water Solubility, LogSw

-2.91

Polar Surface Area

65.678

Acid Dissociation Constant (pKa)

20.41

Base Dissociation Constant (pKb)

-5.49

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

23.80

D103-2362 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with D103-2362 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D103-2362?
Check Price and Availability of D103-2362, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D103-2362 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D103-2362
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D103-2362
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D103-2362 available by request